L6 TEST 2


Mechanisms of Gene Regulation and Promoter Accessibility

  • Context of Gene Expression:

    • Gene expression requires decondensing chromatin to expose promoter regions, allowing the assembly of the transcription initiation complex.

    • Once the transcription initiation complex is fully assembled, transcription itself does not serve as a regulatory control point for protein concentration.

    • RNA polymerase II transcribes at a default baseline rate once initiated; therefore, primary regulation occurs prior to transcription by controlling promoter accessibility.

  • Mediator Complex Overview:

    • Mediator is a multi-protein co-activator complex involved in building the transcription initiation complex.

    • Mediator binds directly to the activation domain of transcription factors that are bound to cis-regulatory sequences.

    • Mediator is distinct from chromatin remodeling complexes and histone acetyltransferases (HATs); it does not alter chromatin structure, modify histones, or decondense DNA.

    • Mediator functions as an physical intermediary bridging transcription factors and RNA polymerase II.

Mediator Complex Structure and Functional Subunits

  • Subunit Organization:

    • Mediator is a large multi-subunit protein complex divided structurally into distinct domains: Head, Middle, and Tail.

    • It contains module-specific subunits, including a cyclin-dependent kinase (CDK) and cyclin module involved in cell cycle regulation.

  • Functional Division of Subunits:

    • Gene Non-Specific Subunits:

      • These subunits directly contact RNA polymerase II.

      • Mutations or functional defects in gene non-specific subunits inhibit the recruitment of RNA polymerase II to all promoters, resulting in a global block of transcription across all genes (lethal mutation).

    • Gene-Specific Subunits:

      • These subunits interact with specific activation domains on targeted transcription factors.

      • Mutations in gene-specific subunits impair transcription only for the specific subset of genes regulated by those corresponding transcription factors, leaving general transcription intact.

  • Mechanism of Polymerase Recruitment:

    • Mediator searches the nucleus to identify inactive, un-busy RNA polymerase II enzymes that are not currently transcribing genes.

    • Upon binding an inactive RNA polymerase II, Mediator transports it to the promoter region.

    • General transcription factors then accurately position RNA polymerase II at the exact initiation site.

Carboxy-Terminal Domain (CTD) of RNA Polymerase II

  • Structural Composition of the CTD:

    • RNA polymerase II possesses a specialized Carboxy-Terminal Domain (CTD) consisting of tandem repeats of a 77\text{-amino-acid} sequence.

    • In humans, this heptapeptide sequence is repeated 5252 times.

    • The heptapeptide repeat contains 55 hydroxyl-bearing amino acids capable of post-translational phosphorylation: Tyrosine, Serine, Threonine, Serine, Serine, Proline, Serine.

  • Phosphorylation State and Functional Transitions:

    • Unphosphorylated CTD:

      • Mediator binds with high affinity exclusively to unphosphorylated CTD tails.

      • An unphosphorylated CTD indicates that the RNA polymerase II is inactive and available for promoter recruitment.

    • Phosphorylated CTD:

      • General transcription factors phosphorylate the CTD upon initiation.

      • Phosphorylation significantly reduces CTD affinity for Mediator, causing Mediator to release RNA polymerase II.

      • Release from Mediator permits RNA polymerase II to clear the promoter and enter the transcription elongation phase.

  • Co-Transcriptional Processing Recruitment:

    • Phosphorylation of the CTD creates high-affinity binding sites that recruit and activate RNA processing enzymes (capping, splicing, and polyadenylation machinery).

    • Processing enzymes dock on the phosphorylated CTD and modify the nascent pre-mRNA transcript co-transcriptionally as it emerges from the exit channel of RNA polymerase II.

Transcript Landmarks and Untranslated Regions (UTRs)

  • Transcript Boundaries and Precise Initiation:

    • Transcription initiates at the precise +1+1 site.

    • Starting transcription upstream of +1+1 incorporates unnecessary nucleotides that interfere with regulation.

    • Starting transcription downstream of +1+1 truncates essential regulatory information stored within the transcript.

  • Functional Regions of mRNA:

    • 5′5' Untranslated Region (5′5' UTR):

      • The sequence located between the 5′5' cap (+1+1 site) and the translation initiation codon.

      • Plays a critical regulatory role in controlling mRNA translation rates and protein expression levels.

    • Coding Sequence (CDS):

      • The internal region bounded by the translation start site and translation stop site that is actively translated into an amino acid sequence.

    • 3′3' Untranslated Region (3′3' UTR):

      • The sequence located between the translation termination codon and the 3′3' end.

      • Regulates mRNA stability, subcellular localization, and translation efficiency.

mRNA 5′5' Capping Architecture and Quality Control

  • Chemical Structure of the 5′5' Cap:

    • The 5′5' cap consists of a 7-methylguanosine7\text{-methylguanosine} moiety attached to the initial nucleotide.

    • The linkage is an atypical 5′ to 5′5'\text{ to }5' triphosphate bridge (5′ to 5′5'\text{ to }5' triphosphate linkage), contrasting with standard 5′ to 3′5'\text{ to }3' phosphodiester bonds.

    • Additional modifications include methylation at the 2′2' hydroxyl (2′2'-O-methylation) of the ribose sugar of the first nucleotide, and occasionally the second nucleotide.

  • Functions of the 5′5' Cap:

    • Protects the 5′5' end of mRNA from enzymatic degradation by 5′ to 3′5'\text{ to }3' exonucleases.

    • Promotes transcription elongation; RNA polymerase II pauses downstream if capping fails to occur.

    • Facilitates nuclear export of mRNA into the cytoplasm.

    • Serves as a recognition signal for the ribosome pre-initiation complex to bind and scan for the translation start site.

    • Differentiates protein-coding mRNAs from non-coding RNA species (such as tRNAs and rRNAs).

    • Establishes physical polarity (5′5' vs. 3′3' orientation) for the protein synthesis machinery.

  • Enzymatic Mechanism and Verification:

    • During chain elongation, incoming ribonucleoside triphosphates (NTPs) lose 22 phosphate groups, leaving 11 phosphate group forming the backbone phosphodiester bond.

    • The absolute +1+1 terminal nucleotide uniquely retains all 33 initial phosphate groups.

    • Capping process:

      1. A terminal phosphatase removes 11 phosphate from the 5′5' end of the nascent transcript, leaving 22 terminal phosphates.

      2. Guanosine Triphosphate (GTP\text{GTP}) is cleaved to Guanosine Monophosphate (GMP\text{GMP}), releasing 22 phosphates to supply catalytic energy.

      3. The resulting GMP\text{GMP} is linked to the 22 remaining transcript phosphates, generating the 5′ to 5′5'\text{ to }5' triphosphate bridge.

      4. Methyltransferases add a methyl group to position 77 of the terminal guanine and the 2′2' hydroxyl of adjacent ribose sugars.

    • Fidelity Control:

      • Capping enzymes strictly require a 5′5' end possessing at least 22 or 33 phosphate groups.

      • Internal cleavage of transcripts by nucleases yields a fragment with only 11 phosphate group at the cleavage site.

      • Damaged or truncated transcripts cannot be capped due to this requirement, resulting in their rapid degradation.

mRNA 3′3' Polyadenylation and Transcription Termination

  • Structure and Function of the Poly-A Tail:

    • Consists of 200 to 250200\text{ to }250 Adenine (A) residues added sequentially to the 3′3' end by Poly-A Polymerase.

    • Poly-A Binding Proteins (PABP) associate with the tail, with approximately 11 PABP molecule binding per every 1212 Adenine residues.

    • Functions to protect the 3′3' end from 3′ to 5′3'\text{ to }5' exonucleolytic decay, promote translation initiation, and confirm transcript structural integrity.

  • Cleavage and Polyadenylation Mechanism:

    • RNA polymerase II does not stop transcription at a precise terminal nucleotide; it transcribes well past the gene boundary.

    • Precise 3′3' end formation requires endonucleolytic cleavage of the pre-mRNA transcript.

    • Consensus Sequence Elements:

      • An upstream AU\text{AU}\text{-rich} element (AAUAAA\text{AAUAAA}).

      • A downstream GU\text{GU}\text{-rich} or U\text{U}\text{-rich} element.

    • Assembly and Processing:

      1. Cleavage and Polyadenylation Specificity Factor (CPSF) binds the upstream AU\text{AU}\text{-rich} site.\n 2. Cleavage Stimulatory Factor (CstF) binds the downstream \text{GU}/\text{U}-rich\text{-rich} site.

      2. The multi-protein cleavage complex endonucleolytically cuts the pre-mRNA between these sites, generating a free 3′-OH3'\text{-OH} group.

      3. Poly-A Polymerase uses the exposed 3′-OH3'\text{-OH} group to synthesize the poly-A tail.

  • Transcription Termination Model:

    • Cleavage releases a downstream RNA fragment containing the GU\text{GU}\text{-rich} element attached to the transcribing RNA polymerase II.

    • Because this cleaved downstream fragment lacks a 5′5' cap or 33 initial phosphates, it cannot be capped.

    • 5′ to 3′5'\text{ to }3' exonucleases rapidly degrade this uncapped fragment.

    • Exonucleolytic degradation proceeds faster than RNA polymerase II elongation, catching up to the enzyme and disrupting the RNA-DNA hybrid holding the complex together, causing RNA polymerase II to dissociate from the DNA template.

Pre-mRNA Splicing Mechanics and Spliceosome Architecture

  • Eukaryotic Gene Architecture:

    • Genes contain non-coding intervening sequences (introns) interspersed between coding sequences (exons).

    • Example: A gene containing 2626 exons contains 2525 intervening introns that must be removed.

    • Splicing must be precise to single-nucleotide resolution; a shift of even 11 nucleotide causes a frameshift mutation that destroys the downstream protein sequence.

  • Conserved Intron Sequences and Nomenclature:

    • 5′5' Splice Site: Conserved GU\text{GU} dinucleotide motif located at the 5′5' intron boundary.

    • 3′3' Splice Site: Conserved AG\text{AG} dinucleotide motif located at the 3′3' intron boundary.

    • Branch Point Adenine: Conserved Adenine (A\text{A}) residue located upstream of the 3′3' splice site.

    • Polypyrimidine Tract: Pyrimidine-rich region (C\text{C} and U\text{U}) situated between the branch point adenine and the 3′3' splice site.

    • Nomenclature Rule: Splice sites are designated relative to the intron boundaries (5′5' splice site is at the intron's 5′5' end; 3′3' splice site is at the intron's 3′3' end).

  • Spliceosome Assembly and Reaction Steps:

    • The spliceosome consists of 55 Small Nuclear RNAs (snRNAs: U1, U2, U4, U5, and U6) bound to auxiliary proteins, forming Small Nuclear Ribonucleoproteins (snRNPs).

    • Over 100100 individual proteins contribute to total spliceosome structure.

    • Sequential Assembly:

      1. U1 snRNP specifically base-pairs with the GU\text{GU} sequence at the 5′5' splice site.

      2. U2 snRNP base-pairs with the sequence surrounding the conserved branch point adenine.

      3. The U4/U5/U6 tri-snRNP complex docks with the U1 and U2 snRNPs.

      4. Conformational rearrangements bring the 5′5' splice site, branch point adenine, and 3′3' splice site into proximity.

      5. Two transesterification reactions cleave the intron, form a lariat intermediate via the branch point adenine, and join the adjacent exons together via a standard phosphodiester bond.